abstract |
The present invention relates to an orally-administered pharmaceutical composition, in the form of capsules with liquid content, which comprises a fixed-dose combination of cinitapride tartrate and simeticone together with at least one surfactant and, optionally, one or more pharmaceutically acceptable excipients, and to the method for obtaining said composition. |